Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2

This investigation demonstrates that ferroptosis inducers like RSL3 can enhance the efficacy of anti-PD-1 therapy by activating the STAT1 signaling pathway and elucidates a previously unrecognized link between ferroptosis and anti-tumor immunity.